Table 2.
Clinical characteristics of patients with and without acute rejection episodes.
| Non-AR | AR | p Value | |
|---|---|---|---|
| Subject (n) | 284 | 63 | |
| Age* | 40.5 ± 11.5 | 39 ± 10.5 | .345 |
| Male (%) | 57.04% | 73.00% | .019 |
| Donor age | 39.4 ± 14 | 44.8 ± 13.7 | .012 |
| Deceased donors | 28.87% | 19.05% | .02 |
| HLA-mismatch (total number) | 3.2 ± 1.6 | 3.4 ± 1.2 | .416 |
| Calcineurin inhibitors | 98.94% | 98.41% | .738 |
| Cyclosporin-based regimen | 78.9% (172) | 21.1%(46) | .096 |
| Tacrolimus-based regimen | 86.3% (101) | 25.4% (16) | .099 |
| Basiliximab induction | 88.4% (167) | 11.6% (22) | .001 |
| Donor serum Cr (mg/dL) | 1.1 ± 0.6 | 0.9 ± 0.3 | .094 |
| Cause of ESRD | .929 | ||
| GN | 114 (40.1) | 27 (42.9) | |
| HTN | 78 (27.5) | 17 (27) | |
| DM | 31 (10.9) | 4 (6.3) | |
| PCKD | 5 (1.8) | 1 (1.6) | |
| Unknown | 43 (15.1) | 11 (17.5) | |
| Others | 13 (4.6) | 3 (4.8) |
AR: acute rejection; ESRD: end stage renal disease; DM: diabetes mellitus; HLA: human leukocyte antigen; HTN: hypertension; GN: glomerulonephritis; PCKD: polycystic kidney disease; n: number; Cr: creatinine.
*
Age when underwent kidney transplantation.